Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa. - Wikidata - wikimedia - TriplyDB

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

http://www.wikidata.org/entity/Q45384947

about

Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention Cystoid macular edema in a patient with Danon disease Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literature Widening use of dexamethasone implant for the treatment of macular edema Management of Cystoid Macular Edema in Retinitis Pigmentosa.NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa.Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.Long-term efficacy and safety of anti-VEGF therapy in retinitis pigmentosa: a case report

P2860

Q28076321-686C2EA5-80FA-41EF-85D1-73BAC039C6E3 Q35036864-7185D380-DFAB-46FA-90CA-E9C1D66A3744 Q35618296-B3A6F1D5-28B5-440A-937A-901142ABCC4C Q38599000-A6711920-90BF-47AC-818A-7BFE22B143FD Q38982477-34F26074-9628-435A-93BC-58E915A0B5FB Q39066194-2245A2FC-0345-4DF1-A1B0-FD98FD13E3BC Q40343479-63C6EBE8-B6C3-4202-976F-4504DEF477D3 Q41237469-57E0C266-EF16-48DC-82AB-3AE2E1D5A341 Q42375768-4D47F279-BC04-4333-81D4-16776D3F6CD8 Q44536567-3E6A3F0E-088B-4022-B395-46CB89AB3C2F Q58741839-00BB6F52-9CF8-4691-B5F0-22895061AA7C

P2860

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

http://www.wikidata.org/entity/Q45384947

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

@en

type

label

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

@en

prefLabel

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

@en

P1433

Q45384947-A7C4044D-419E-4DCA-9AA1-BFDD2416604D

P1476

Q45384947-B4715D9A-13FE-4193-A18E-FBBE64DA7B2E

P2093

Q45384947-20D71944-F0BE-429E-83CD-0DBD3AC22D79

Q45384947-359F3497-97D0-4993-8C4E-77ED9F62D67C

Q45384947-3B733ECE-0778-432F-A0DD-7940A194FD88

Q45384947-E4CA6318-2313-4BA5-9219-E32001675FDC

Q45384947-E99B7A1B-4E6E-4029-9B33-370858D5097B

P2860

Q45384947-05AF6946-2CC2-458F-AE18-8DFF9BB5D6E2

Q45384947-09DC688E-5A86-4048-9D3E-2D05A1A6BFA2

Q45384947-1CC70A1A-A760-49B8-B1AA-1F849DA1EEDB

Q45384947-2287E0B6-FC10-425F-809E-7B97D7FBBE9C

Q45384947-2E35E080-8047-4AE1-94ED-580A3A8D6612

Q45384947-5A4929DC-701D-4BEE-B911-5A1FA9D48D50

Q45384947-65F2A20C-FC6B-4D93-8B18-4B81E486EDF6

Q45384947-75F12729-2589-408C-A9CE-3B4E844A5CB5

Q45384947-77BEC149-4A71-4DB9-BC6D-DF696DA4F5AF

Q45384947-9B1B2A1D-B390-452F-9842-1F2BBA1F3399

P304

Q45384947-5015A9C3-B268-4C56-8569-F26178F2D80E

P31

Q45384947-5D5161F6-1670-4B52-B8A4-E9EEABE82E06

P356

Q45384947-D8A308AE-18B6-493B-B7D5-61107898E812

P433

Q45384947-5282A66B-B05D-4E29-A3BF-3DCC3E8CC673

P478

Q45384947-7AFAD870-856E-45E3-BA99-848C2B94835C

P577

Q45384947-7F85653B-2C9C-40AB-9CF6-0D95DAEA13D2

P698

Q45384947-2929D307-9B87-4BA0-9F02-5DD1D43E2ACF

P921

Q45384947-752E7D94-1C94-41B4-A71C-2EFD6865D56D

P356

02713680802710692

P1433

Current Eye Research

P1476

Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.

@en

P2093

Alper Sengul

http://www.w3.org/2001/XMLSchema#string

Erdal Yuzbasioglu

http://www.w3.org/2001/XMLSchema#string

Halil Bahcecioglu

http://www.w3.org/2001/XMLSchema#string

Ozgur Artunay

http://www.w3.org/2001/XMLSchema#string

Rifat Rasier

http://www.w3.org/2001/XMLSchema#string

P2860

Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa

The role of carbonic anhydrase inhibitors in the management of macular edema.

The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema.

Foveal lesions seen in retinitis pigmentosa.

Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

The association between visual acuity and central retinal thickness in retinitis pigmentosa.

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.

Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization.

Penetration of bevacizumab through the retina after intravitreal injection in the monkey.

P304

231-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02713680802710692

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19274531

http://www.w3.org/2001/XMLSchema#string

P921